SUNOPTA INC (STKL)

CA8676EP1086 - Common Stock

5.86  -0.11 (-1.84%)

After market: 5.88 +0.02 (+0.34%)

Fundamental Rating

3

Overall STKL gets a fundamental rating of 3 out of 10. We evaluated STKL against 92 industry peers in the Food Products industry. While STKL is still in line with the averages on profitability rating, there are concerns on its financial health. STKL is quite expensive at the moment. It does show a decent growth rate.



4

1. Profitability

1.1 Basic Checks

In the past year STKL was profitable.
In the past year STKL has reported a negative cash flow from operations.
In the past 5 years STKL reported 4 times negative net income.
STKL had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

STKL has a worse Return On Assets (-22.83%) than 80.22% of its industry peers.
Looking at the Return On Equity, with a value of -89.83%, STKL is doing worse than 81.32% of the companies in the same industry.
STKL has a better Return On Invested Capital (7.13%) than 70.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for STKL is below the industry average of 8.95%.
The last Return On Invested Capital (7.13%) for STKL is above the 3 year average (4.60%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -22.83%
ROE -89.83%
ROIC 7.13%
ROA(3y)-9.36%
ROA(5y)-3.51%
ROE(3y)-34.91%
ROE(5y)-17.74%
ROIC(3y)4.6%
ROIC(5y)N/A

1.3 Margins

STKL has a better Operating Margin (7.51%) than 69.23% of its industry peers.
In the last couple of years the Operating Margin of STKL has grown nicely.
STKL has a Gross Margin of 19.04%. This is comparable to the rest of the industry: STKL outperforms 49.45% of its industry peers.
In the last couple of years the Gross Margin of STKL has grown nicely.
Industry RankSector Rank
OM 7.51%
PM (TTM) N/A
GM 19.04%
OM growth 3Y68.62%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.9%
GM growth 5Y15.71%

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), STKL is destroying value.
Compared to 1 year ago, STKL has more shares outstanding
STKL has more shares outstanding than it did 5 years ago.
STKL has a worse debt/assets ratio than last year.

2.2 Solvency

STKL has an Altman-Z score of 1.42. This is a bad value and indicates that STKL is not financially healthy and even has some risk of bankruptcy.
STKL's Altman-Z score of 1.42 is on the low side compared to the rest of the industry. STKL is outperformed by 67.03% of its industry peers.
STKL has a Debt/Equity ratio of 1.62. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of STKL (1.62) is worse than 83.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.62
Debt/FCF N/A
Altman-Z 1.42
ROIC/WACC0.87
WACC8.18%

2.3 Liquidity

A Current Ratio of 1.27 indicates that STKL should not have too much problems paying its short term obligations.
STKL has a worse Current ratio (1.27) than 61.54% of its industry peers.
A Quick Ratio of 0.61 indicates that STKL may have some problems paying its short term obligations.
The Quick ratio of STKL (0.61) is worse than 63.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.61

5

3. Growth

3.1 Past

STKL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
STKL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.00%.
Measured over the past years, STKL shows a decrease in Revenue. The Revenue has been decreasing by -4.27% on average per year.
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)4%
Revenue growth 3Y-7.22%
Revenue growth 5Y-4.27%
Sales Q2Q%-17.72%

3.2 Future

The Earnings Per Share is expected to grow by 74.07% on average over the next years. This is a very strong growth
STKL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.70% yearly.
EPS Next Y55.11%
EPS Next 2Y74.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.02%
Revenue Next 2Y12.7%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

STKL is valuated quite expensively with a Price/Earnings ratio of 65.11.
STKL's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of STKL to the average of the S&P500 Index (30.69), we can say STKL is valued expensively.
STKL is valuated quite expensively with a Price/Forward Earnings ratio of 27.63.
The rest of the industry has a similar Price/Forward Earnings ratio as STKL.
STKL's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.55.
Industry RankSector Rank
PE 65.11
Fwd PE 27.63

4.2 Price Multiples

STKL's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.53

4.3 Compensation for Growth

STKL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
STKL's earnings are expected to grow with 74.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.18
PEG (5Y)N/A
EPS Next 2Y74.07%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

STKL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SUNOPTA INC

NASDAQ:STKL (10/30/2024, 8:00:00 PM)

After market: 5.88 +0.02 (+0.34%)

5.86

-0.11 (-1.84%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap684.69M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 65.11
Fwd PE 27.63
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.83%
ROE -89.83%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.51%
PM (TTM) N/A
GM 19.04%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 1.62
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.27
Quick Ratio 0.61
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y55.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4%
Revenue growth 3Y-7.22%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y